scholarly journals Profile of chronic kidney disease modifiable risk factors in a rural community of south east Nigeria

2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Adaobi I. Bisi-Onyemaechi ◽  
Henrietta U. Okafor ◽  
Maduka D. Ughasoro
2019 ◽  
pp. 29-38
Author(s):  
Hania Kassem ◽  
Bernard G. Jaar

Chronic kidney disease (CKD) represents a significant public health burden worldwide and several risk factors have been identified over the years; these have been well-described in the medical literature. Common risk factors such as diabetes mellitus and hypertension will be described in other chapters. While this chapter will focus mainly on CKD risk factors observed in developed countries, several of these are also observed in developing countries. It is now well-established that some risk factors are modifiable while others are non-modifiable. In this chapter, we will explore several of these non-modifiable risk factors in more detail, such as age, gender, race, family history, and low birth weight. But we will also discuss some of the modifiable risk factors such as kidney stones, obstructive sleep apnea, smoking, drugs (excluding NSAIDs), diet, obesity, metabolic syndrome, and hyperuricemia. We will provide a balanced and up to date review of the evidence linking these risk factors with CKD.


2011 ◽  
Vol 65 (Suppl 1) ◽  
pp. A141-A141
Author(s):  
R. Oluyombo ◽  
A. Akinsola ◽  
O. Ayodele ◽  
A. Onayade ◽  
F. Arogundade ◽  
...  

2013 ◽  
Vol 57 (4) ◽  
pp. 357-362 ◽  
Author(s):  
Stefan Herget-Rosenthal ◽  
Dorothea Dehnen ◽  
Andreas Kribben ◽  
Thomas Quellmann

2008 ◽  
Vol 149 (15) ◽  
pp. 691-696
Author(s):  
Dániel Bereczki

Chronic kidney diseases and cardiovascular diseases have several common risk factors like hypertension and diabetes. In chronic renal disease stroke risk is several times higher than in the average population. The combination of classical risk factors and those characteristic of chronic kidney disease might explain this increased risk. Among acute cerebrovascular diseases intracerebral hemorrhages are more frequent than in those with normal kidney function. The outcome of stroke is worse in chronic kidney disease. The treatment of stroke (thrombolysis, antiplatelet and anticoagulant treatment, statins, etc.) is an area of clinical research in this patient group. There are no reliable data on the application of thrombolysis in acute stroke in patients with chronic renal disease. Aspirin might be administered. Carefulness, individual considerations and lower doses might be appropriate when using other treatments. The condition of the kidney as well as other associated diseases should be considered during administration of antihypertensive and lipid lowering medications.


Sign in / Sign up

Export Citation Format

Share Document